Wound infiltration with ropivacaine and bupivacaine for pain after inguinal herniotomy

In a double‐blind, randomized study, 32 patients scheduled for elective inguinal herniotomy under general anaesthesia received subcutaneous infiltration with 40 ml ropivacaine 2.5 mg/ml or bupivacaine. Postoperative pain intensity was assessed repeatedly for 24 hours at rest, during cough and movement on a visual analogue scale (VAS) and by means of pressure algometry. No differences between pain intensities or wound tenderness were found between the groups. The demand for analgesics was similar in the two groups. We conclude that incisional ropivacaine is as effective as bupivacaine in the management of post‐herniotomy pain.

[1]  J. Dahl,et al.  The effects of wound infiltration with bupivacaine versus saline on postoperative pain and opioid requirements after herniorrhaphy , 1994, Acta anaesthesiologica Scandinavica.

[2]  H. Kehlet,et al.  Wound infiltration with local anaesthetics for postoperative pain relief , 1994, Acta anaesthesiologica Scandinavica.

[3]  R. Hickey,et al.  A comparative study of 0.25% ropivacaine and 0.25% bupivacaine for brachial plexus block. , 1992, Anesthesia and analgesia.

[4]  I. Cederholm,et al.  Skin Blood Flow after Intradermal Injection of Ropivacaine in Various Concentrations with and without Epinephrine Evaluated by Laser Doppler Flowmetry , 1992, Regional Anesthesia & Pain Medicine.

[5]  B. Covino,et al.  Treatment of acute systemic toxicity after the rapid intravenous injection of ropivacaine and bupivacaine in the conscious dog. , 1991, Anesthesia and analgesia.

[6]  R. Carpenter,et al.  Comparison between Ropivacaine and Bupivacaine after Subcutaneous Injection in Pigs: Cutaneous Blood Flow and Surgical Bleeding , 1991, Regional Anesthesia & Pain Medicine.

[7]  R. Hickey,et al.  A comparison of ropivacaine 0.5% and bupivacaine 0.5% for brachial plexus block. , 1991, Anesthesiology.

[8]  H. Kehlet,et al.  Pressure pain thresholds in volunteers and herniorrhaphy patients , 1990, Acta anaesthesiologica Scandinavica.

[9]  D. Denson,et al.  Pharmacodynamics and Pharmacokinetics of Epidural Ropivacaine in Humans , 1990, Anesthesia and analgesia.

[10]  Alistair Lee,et al.  Acute Toxicity of Ropivacaine Compared with That of Bupivacaine , 1989, Anesthesia and analgesia.

[11]  W. Runciman,et al.  Myocardial and Cerebral Drug Concentrations and the Mechanisms of Death after Fatal Intravenous Doses of Lidocaine, Bupivacaine, and Ropivacaine in the Sheep , 1989, Anesthesia and analgesia.

[12]  W. Runciman,et al.  Hemodynamic and Central Nervous System Effects of Intravenous Bolus Doses of Lidocaine, Bupivacaine, and Ropivacaine in Sheep , 1989, Anesthesia and analgesia.

[13]  D. Kopacz,et al.  Effect of ropivacaine on cutaneous capillary blood flow in pigs. , 1989, Anesthesiology.

[14]  B. Covino,et al.  Comparative Pharmacokinetics of Bupivacaine and Ropivacaine, a New Amide Local Anesthetic , 1988, Anesthesia and analgesia.

[15]  B. Covino,et al.  Comparative Motor‐Blocking Effects of Bupivacaine and Ropivacaine, A New Amino Amide Local Anesthetic, in the Rat and Dog , 1988, Anesthesia and analgesia.

[16]  B. Akerman,et al.  Primary evaluation of the local anaesthetic properties of the amino amide agent ropivacaine (LEA 103) , 1988, Acta anaesthesiologica Scandinavica.